← Data Explorer · All industries

Biological products, (no diagnostic substances) (SIC 2836)

Major group 28: Chemicals and allied products

Part of 283 Drugs

Companies with SIC industry code 2836. Companies with no code (SIC 0) and shell companies (SIC 9995) are left out.

As of2020 Q4
Data cover 2000 Q4 – 2020 Q4, quarterly.

The tiles, heatmap and tables below use the industry’s S&P 500 companies.

Companies in 2020 Q4 8
Average profit weight between them 0.46

Average profit weight in the industry over time

The mean profit weight over every ordered pair of the industry’s companies, each quarter: S&P 500 companies (solid) and all companies (faded). Click a quarter to show it.

    Computed from the current data release, using every firm in the sample. Published papers used earlier releases and samples, so their figures differ slightly.

    Show the numbers

    Profit weights between the 8 largest companies, 2020 Q4

    Each cell is the profit weight of the row company’s shareholders on the column company (darker: higher). Companies are ordered so that tightly linked groups form blocks. Largest means most reported owners. Click a cell to compare the two companies.

    Investors who drive it, 2020 Q4

    The investors that contribute most to the industry’s average profit weight: roughly, those holding sizeable stakes in many of its companies at once. Investor types are inferred from the forms each investor files with the SEC and are under review. Anyone filing Forms 3/4/5 counts as an insider unless they also file 13F, in which case they count as an asset manager (such as Carl Icahn).

    • Big Three
    • Asset manager
    • Non-financial blockholder
    • Activist
    • Insider
    #InvestorTypeCompanies held hereShare of the averageSEC CIKReport
    1 Vanguard Group Inc Big Three 833% 102909
    2 BlackRock Inc. Big Three 831% 1364742
    3 State Street Corp Big Three 89% 93751
    4 Capital International Inc /Ca/*Capital International Sarl*Capital International LTD /Ca/*Capital Research Global Investors*Capital World Investors*Capital International Investors*Capital Bank & Trust Co Asset manager 46% 732812
    5 Baker Bros. Advisors LP Asset manager 44% 1263508
    6 FMR Llc*Fil LTD Asset manager 73% 315066
    7 Wellington Management Group LLP Asset manager 73% 902219
    8 Price T Rowe Associates Inc /MD/ Asset manager 62% 80255
    9 Geode Capital Management, LLC Asset manager 81% 1214717
    10 Primecap Management Co/Ca/ Asset manager 20.9% 763212
    11 Northern Trust Corp Asset manager 80.8% 73124
    12 Royce & Associates LP Asset manager 60.8% 38777
    13 JPMorgan Chase & Co Asset manager 80.6% 19617
    14 Norges Bank Asset manager 60.5% 1374170
    15 Bank of New York Mellon Corp Asset manager 80.5% 1629943
    16 Janus Henderson Group PLC Asset manager 70.5% 1274173
    17 UBS Asset Management Americas Inc*Ubs Group AG Asset manager 80.5% 1610520
    18 Renaissance Technologies LLC Asset manager 60.5% 1037389
    19 Hillhouse Capital Advisors, LTD. Asset manager 20.3% 1510589
    20 Morgan Stanley Asset manager 80.2% 895421
    21 Bank of America Corp /DE/ Asset manager 80.2% 70858
    22 Legal & General Group PLC Asset manager 80.2% 764068
    23 Wells Fargo & Company/Mn Asset manager 80.2% 72971
    24 Nuveen Asset Management, LLC Asset manager 80.2% 1521019
    25 Deutsche Bank Ag\ Asset manager 80.1% 948046

    The companies, 2020 Q4

    CompanyReported ownersReported ownershipSEC CIKReport
    Abbvie Inc SIC 2836 · S&P 500 246767.88%1551152
    Amgen Inc SIC 2836 · S&P 500 204775.93%318154
    Gilead Sciences Inc SIC 2836 · S&P 500 148377.96%882095
    Biogen Inc SIC 2836 · S&P 500 99784.51%875045
    Alexion Pharmaceuticals Inc SIC 2836 · S&P 500 79290.48%899866
    Incyte Corp SIC 2836 · S&P 500 49793.18%879169
    Hookipa Pharma Inc SIC 2836 · S&P 500 · dual class 7167.30%1760542
    Aligos Therapeutics Inc SIC 2836 · S&P 500 · dual class 5271.48%1799448

    Something look wrong? Report a problem with this page.

    These pages are for looking up individual companies and investors. Please don’t copy them with automated tools. If you need the full data, request a download: it is free of charge for academic research.